Provided by Tiger Trade Technology Pte. Ltd.

TIGERMED

41.160
0.000
Volume:- -
Turnover:- -
Market Cap:35.44B
PE:33.92
High:41.160
Open:41.160
Low:41.160
Close:41.160
52wk High:56.735
52wk Low:27.989
Shares:861.00M
HK Float Shares:123.12M
Volume Ratio:- -
T/O Rate:- -
Dividend:0.15
Dividend Rate:0.36%
EPS(LYR):1.214
ROE:1.09%
ROA:1.43%
PB:1.56
PE(LYR):33.92
PS:4.17

Loading ...

TIGERMED to Seek Shareholder Approval for A-Share Repurchase at 9 June 2026 EGM

Bulletin Express
·
May 19

TIGERMED Launches RMB500 Million–1 Billion A-Share Buyback for Incentives and Capital Reduction

Bulletin Express
·
May 19

Schroders PLC Reduces Stake in Tigermed by 579,300 Shares at Approximately HK$35.87 per Share

Stock News
·
May 15

Two Company Controllers Face Investigation in a Single Day: Compliance Storm Hits TIGERMED and Dian Diagnostics

Deep News
·
May 15

Top Executives of Leading Clinical CRO Firm TIGERMED Under Investigation; Fullgoal Funds' 20.97 Million Share Bet Raises Questions

Deep News
·
May 14

Data Center Power Business Soars at Shenzhen Honor Electronic; GPU Power Project Secured with Alphabet

Stock News
·
May 13

Dian Diagnostics Director Ye Xiaoping Under CSRC Investigation for Alleged Disclosure Violations Regarding Tigermed Shareholding Changes

Stock News
·
May 13

Tigermed (03347) Clarifies: All Historical Share Reductions by Actual Controllers Were Properly Announced

Stock News
·
May 13

Tigermed Announces Share Buyback Plan for A-Shares Valued at 5 to 10 Billion Yuan

Stock News
·
May 13

Norwegian Central Bank Increases Stake in TIGERMED with 813,800 Shares at HK$38.65 Each

Stock News
·
May 13

Regulatory Action Initiated Against Top Executives of Tigermed

Stock News
·
May 12

TigerMed Shareholder Cao Xiaochun Pledges 18.5 Million Shares

Stock News
·
May 12

Tigermed discloses CSRC probe into two controlling shareholders over shareholding disclosure practices

Bulletin Express
·
May 12

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

TIGERMED Maintains Stable Share Structure in April 2026; Treasury Shares Stand at 5.88 Million A Shares

Bulletin Express
·
May 06

Goldman Sachs Lowers Tigermed Target Price to HK$59.4, Keeps "Buy" Rating

Stock News
·
May 04

泰格医药2025年业绩稳步增长,强化全球临床服务与数字化布局

Bulletin Express
·
Apr 29

Tigermed Calls 2026 H-Shareholders’ Meeting to Seek Share Buy-Back Mandate

Bulletin Express
·
Apr 29

Tigermed Schedules 2026 AGM to Vote on 2025 Financials, Director Slate and Dual H-Share Mandates

Bulletin Express
·
Apr 29

Tigermed’s 2025 Sustainability Report: SBTi-Validated Emission Targets, MSCI ESG Upgrade to AAA and Net Profit of RMB 887.89 Million

Bulletin Express
·
Apr 29